An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma.

CN Sternberg, ID Davis, KC Deen, E Sigal, RE. Hawkins

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)342-350
    Number of pages8
    JournalOncology
    Volume87
    Issue number6
    DOIs
    Publication statusPublished - 6 Sep 2014

    Cite this